justbacked
← All jobs
Cloverleaf Bio

Scientist, Oligonucleotide Synthesis

Boston, MA · Full-time

Seed · $33M · 74d ago Posted 5d ago
Have your AI draft the answers and brief you on Cloverleaf Bio→

Why join Cloverleaf Bio?

The bet: a new class of RNA medicines could become a core oncology tool, and Cloverleaf Bio, a New Haven biotech, is building the platform behind it. If it works, oncology gets a new kind of medicine that Eli Lilly, AbbVie and Boehringer Ingelheim already want a piece of. Its $33M seed beats 90% of its stage's rounds, and a team of 1-10 has room for early hires to shape the science.

JustBacked's take, based on Cloverleaf Bio's own site and its funding and hiring data.

The full description is on the company's site.